Related references
Note: Only part of the references are listed.Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment
Rebeccah J. Mathews et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Dendritic cells activated by double-stranded RNA induce arthritis via autocrine type I IFN signaling
Sudeep Chenna Narendra et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs
F. Mimoto et al.
MOLECULAR IMMUNOLOGY (2014)
Gene expression analysis in RA: towards personalized medicine
A. N. Burska et al.
PHARMACOGENOMICS JOURNAL (2014)
The function of Fcγ receptors in dendritic cells and macrophages
Martin Guilliams et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Personalized medicine: predicting responses to therapy in patients with RA
Marianne van den Broek et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
The DHX33 RNA Helicase Senses Cytosolic RNA and Activates the NLRP3 Inflammasome
Hiroki Mitoma et al.
IMMUNITY (2013)
GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis
Isabel Acosta-Colman et al.
PHARMACOGENOMICS (2013)
Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis
Jing Cui et al.
PLOS GENETICS (2013)
Properties of mouse and human IgG receptors and their contribution to disease models
Pierre Bruhns
BLOOD (2012)
An integrated map of genetic variation from 1,092 human genomes
David M. Altshuler et al.
NATURE (2012)
Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis
Sophine B. Krintel et al.
PHARMACOGENETICS AND GENOMICS (2012)
Genetic Basis of Autoantibody Positive and Negative Rheumatoid Arthritis Risk in a Multi-ethnic Cohort Derived from Electronic Health Records
Fina Kurreeman et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis
Carine Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis
Leonid Padyukov et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ARTHRITIS AND RHEUMATISM (2011)
Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to antitumour necrosis factor alpha therapy in rheumatoid arthritis
J. D. Canete et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Gene-Environment Interaction Between the DRB1 Shared Epitope and Smoking in the Risk of Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis
Erneli Lundstrom et al.
ARTHRITIS AND RHEUMATISM (2009)
Differences in binding and effector functions between classes of TNF antagonists
Taruna Arora et al.
CYTOKINE (2009)
Sensors of the innate immune system: their mode of action
Roberto Baccala et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
FcγRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients
Marcia Paiva et al.
CANCER GENETICS AND CYTOGENETICS (2008)
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
Antonino Musolino et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
FCGR2A and FCGR3A Polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab
Wu Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Pharmacogenomic analysis of a randomized phase II trial (BOND 2) of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer
W. Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro
Shuying Yang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Molecular aspects of human FcγR interactions with IgG:: Functional and therapeutic consequences
Sophie Siberil et al.
IMMUNOLOGY LETTERS (2006)
Human Fc receptors: Critical targets in the treatment of autoimmune diseases and transplant rejections
Elena Ivan et al.
HUMAN IMMUNOLOGY (2006)
Toll-like receptors and RNA helicases: Two parallel ways to trigger antiviral responses
Etienne Meylan et al.
MOLECULAR CELL (2006)
Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis
KA Kuhn et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The activation-induced expression of DHX32 in Jurkat T cells is specific and involves calcium and nuclear factor of activated T cells
Z Alli et al.
CELLULAR IMMUNOLOGY (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
The complex interplay among factors that influence allelic association
KT Zondervan et al.
NATURE REVIEWS GENETICS (2004)
The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept
LA Criswell et al.
ARTHRITIS AND RHEUMATISM (2004)
Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma
WK Weng et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The novel helicase homologue DDX32 is down-regulated in acute lymphoblastic leukemia
M Abdelhaleem
LEUKEMIA RESEARCH (2002)
Inflammation in autoimmunity: receptors for IgG revisited
HM Dijstelbloem et al.
TRENDS IN IMMUNOLOGY (2001)
Share Paper
